(Q46937052)

26 December 2017

title

Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress (English)

1 reference

26 December 2017

0 references

1

1 reference

26 December 2017

Huiyong Yin

object named as

Huiyong Yin

2

0 references

author name string

Joshua D Brooks

3

1 reference

26 December 2017

Stephanie Sanchez

4

1 reference

26 December 2017

L Jackson Roberts

5

1 reference

26 December 2017

Jason D Morrow

6

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

26 December 2017

published in

Methods in Enzymology

1 reference

26 December 2017

volume

433

1 reference

26 December 2017

page(s)

113-126

1 reference

26 December 2017

Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

The oxidative modification hypothesis of atherogenesis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Platelet activation in obese women: role of inflammation and oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

The isoprostanes: unique products of arachidonic acid oxidation-a review

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Plasma F2-isoprostanes and coronary artery calcification: the CARDIA Study

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Role of free radicals and catalytic metal ions in human disease: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

HPLC-atmospheric pressure chemical ionization MS/MS for quantification of 15-F2t-isoprostane in human urine and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Lipidomic analysis of twenty-seven prostanoids and isoprostanes by liquid chromatography/electrospray tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

F2-isoprostanes as markers of oxidative stress in vivo: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Quantification of F2-isoprostanes as a biomarker of oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

IPF2alpha-I: an index of lipid peroxidation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Identification of the major urinary metabolite of the F2-isoprostane 8-iso-prostaglandin F2alpha in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

The isoprostanes: a perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Nomenclature of isoprostanes: a proposal.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Isoprostane measurement in plasma and urine by liquid chromatography-mass spectrometry with one-step sample preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Benefits of prolonged gradient separation for high-performance liquid chromatography-tandem mass spectrometry quantitation of plasma total 15-series F-isoprostanes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

Control of matrix effects in the analysis of urinary F2-isoprostanes using novel multidimensional solid-phase extraction and LC-MS/MS

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933006-1

7 January 2021

10.1016/S0076-6879(07)33006-1

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017